bit.bio

Techbio 2.0

This company develops induced pluripotent stem cell models and artificial intelligence platforms to provide predictive drug discovery data for pharmaceutical and biotechnology researchers.

Bitrobius Genetics

This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.

Axol Bioscience

This company supplies human induced pluripotent stem cells and reagents to biopharmaceutical and academic organisations for drug discovery and disease modelling.

clock.bio

This biotechnology company develops regenerative therapies for patients with age-related diseases by using gene-editing technology to decode cellular rejuvenation programs in human stem cells.

Cellino

The company develops an autonomous biomanufacturing platform to produce personalised stem cell therapies for patients with chronic degenerative diseases.

Transforming cells into cures

This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.

Stämm Biotech

This company develops automated microfluidic bioreactors for continuous production of biologics and cell therapies for pharmaceutical, biotechnology and cultivated meat organisations.

iOrganBio

This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.